Antacid

DRUG7 trials

Sponsors

University of Colorado, Denver, Pfizer, University of Wisconsin, Madison, H. Lundbeck A/S, Uriach Consumer Healthcare

Conditions

Autism Spectrum DisorderCerebral Arterial DiseasesConstipationDiarrheaGastric RefluxGastro-Intestinal DisorderHIV InfectionsHealthy

Early Phase 1

Human Cerebral Blood Flow Regulation

CompletedNCT04265053

University of Wisconsin, MadisonCerebral Arterial Diseases

Start: 2021-04-12End: 2025-05-31Updated: 2025-10-03

Phase 1

Effect of Antacids on the Pharmacokinetics of Raltegravir

CompletedNCT00944307

University of Colorado, DenverHIV Infections

Start: 2009-07-31End: 2009-12-31Updated: 2017-06-28

Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food

CompletedNCT02097329

Start: 2014-04-30End: 2014-06-30Updated: 2014-06-19

A Study to Evaluate a New Tablet Formulation of Lu AG06466 in Healthy Participants

CompletedNCT05028673

H. Lundbeck A/SHealthy

Start: 2021-08-23End: 2021-12-29Updated: 2022-01-21

Phase 2

Microbiota Transfer Therapy for Children and Adults With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders

RecruitingNCT06321796

Gut-Brain-Axis Therapeutics Inc.Pitt Hopkins Syndrome

Start: 2024-02-27End: 2025-05-31Target: 20Updated: 2024-03-20

Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders

Active, not recruitingNCT06503978

Gut-Brain-Axis Therapeutics Inc.Autism Spectrum Disorder, Constipation, Diarrhea +1

Start: 2024-08-20End: 2026-08-17Target: 60Updated: 2024-09-25

Unknown Phase

Efficacy and Speed of Action of a Product to Control Gastric Hydration and Gastroesophageal Reflux

Uriach Consumer HealthcareGastric Reflux, Hyperactivity; Stomach, Oesophageal Reflux

Start: 2021-09-09End: 2023-06-30Target: 50Updated: 2023-05-26